EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut Microbiome as a Source of Probiotic Drugs for Parkinson’s Disease

Elena U Poluektova, Alla Stavrovskaya, Anastasia Pavlova, Roman Yunes iD, Maria Marsova iD, Tatiana Koshenko iD, Sergey Illarioshkin iD, Valery Danilenko iD

International Journal of Molecular Sciences · 23.09.2025 · 26 (19) · 9290

DOI: 10.3390/ijms26199290 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.09.2025. Verfasst von Elena U Poluektova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow 119991, Russia. Hauptthemen laut MEDLINE: Parkinson Disease, Gastrointestinal Microbiome, Probiotics. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation for major scientific projects in priority areas of scientific and technological development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is a progressive, irreversible neurodegenerative disorder characterized by motor impairments and a wide spectrum of non-motor symptoms, including gastrointestinal dysfunction, sleep disturbances, depression, and cognitive decline. These manifestations arise from disturbances across multiple systems—gastrointestinal, neuroendocrine, immune, enteric, and central nervous systems. Alterations in the gut microbiota may play a causal role in PD onset and frequently accompany disease progression. The gut–brain axis, particularly the vagus nerve, is increasingly recognized as a key communication pathway whose dysregulation contributes to systemic dysfunction and the breakdown of homeostasis, ultimately driving PD pathology. Currently, there is no cure for PD, and existing treatments primarily target symptom relief. Effective management of PD requires a comprehensive approach that integrates multiple pharmacologically active agents aimed at restoring impaired organ functions and, when possible, neutralizing toxic factors that accelerate disease progression. One promising therapeutic avenue lies in functional gut bacteria, which form the basis for developing live biotherapeutic products, postbiotics, and bacterial vesicles. In this review, we summarize current data on the effects of probiotics in PD, drawing on both animal models and clinical studies. We highlight the role of probiotics in modulating PD pathophysiology and discuss their potential as adjunctive therapeutic agents. To provide a broader perspective, we also include sections describing the clinical manifestations of PD, gut microbiota alterations associated with the disease, and the role of artificial intelligence, particularly machine learning, in constructing functional models of PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseGastrointestinal MicrobiomeProbioticsHumansAnimals

Stichwörter der Autor:innen

Parkinson’s diseaseextracellular vesicleslive biotherapeutic productsmicrobiotapostbioticsprobiotics

Autor:innen und Institutionen

  • Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow 119991, Russia.
  • Russian Сenter of Neurology and Neurosciences, Moscow 125367, Russia.

ORCID-Profile: Roman Yunes, Maria Marsova, Tatiana Koshenko, Sergey Illarioshkin, Valery Danilenko

Förderung

  • Ministry of Science and Higher Education of the Russian Federation for major scientific projects in priority areas of scientific and technological development

Zitieren

APA

Poluektova, E. U., Stavrovskaya, A., Pavlova, A., Yunes, R., Marsova, M., Koshenko, T., Illarioshkin, S., & Danilenko, V. (2025). Gut Microbiome as a Source of Probiotic Drugs for Parkinson’s Disease. International Journal of Molecular Sciences, 26(19), 9290. https://doi.org/10.3390/ijms26199290

Vancouver

Poluektova EU, Stavrovskaya A, Pavlova A, Yunes R, Marsova M, Koshenko T, et al. Gut Microbiome as a Source of Probiotic Drugs for Parkinson’s Disease. International Journal of Molecular Sciences. 2025;26(19):9290. doi:10.3390/ijms26199290

BibTeX
@article{Poluektova2025,
  author = {Poluektova, Elena U and Stavrovskaya, Alla and Pavlova, Anastasia and Yunes, Roman and Marsova, Maria and Koshenko, Tatiana and Illarioshkin, Sergey and Danilenko, Valery},
  title = {Gut Microbiome as a Source of Probiotic Drugs for Parkinson’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {19},
  pages = {9290},
  doi = {10.3390/ijms26199290}
}
Kostenlos starten →